Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aptargroup Inc ATR

Consumer Cyclical Packaging & Containers
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. It operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and... see more

Recent & Breaking News (NYSE:ATR)

Aptar Announces the Appointment of Isabel Marey-Semper to the Board of Directors

Business Wire May 1, 2019

Aptar Reports First Quarter Results

Business Wire April 30, 2019

Aptar Announces New $350 Million Share Repurchase Authorization and Raises Quarterly Dividend

Business Wire April 18, 2019

Aptar Pharma’s Bidose Nasal Drug Delivery Device Approved by U.S. FDA for Breakthrough Treatment of Depression

Business Wire March 18, 2019

Aptar Reports Fourth Quarter and Annual Results

Business Wire February 20, 2019

Earnings Scheduled For February 20, 2019

Benzinga.com  February 20, 2019

Aptar Joins the World Business Council for Sustainable Development

Business Wire February 5, 2019

Consolidated Research: 2019 Summary Expectations for Post, Westlake Chemical, Repligen, Weingarten Realty Investors, AptarGroup, and At Home Group — Fundamental Analysis, Key Performance Indications

GlobeNewswire January 23, 2019

Aptar Signs the New Plastics Economy Global Commitment

Business Wire January 18, 2019

Aptar Declares Quarterly Dividend

Business Wire January 17, 2019

Aptar Announces Quarterly Conference Call and Annual Meeting Information

Business Wire January 9, 2019

Aptar Announces Price Increases

Business Wire November 16, 2018

Aptar Reports Third Quarter Results

Business Wire November 1, 2018

Earnings Scheduled For November 1, 2018

Benzinga.com  November 1, 2018

Aptar Appoints Chief Human Resources Officer

Business Wire October 25, 2018

Analysis: Positioning to Benefit within Ligand Pharmaceuticals, AptarGroup, Unifirst, Universal, AutoZone, and Churchill Downs — Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire October 22, 2018

Aptar Declares Quarterly Dividend

Business Wire October 18, 2018

Glenroy Inc. Selected as Exclusive Converter of Premade STANDCAP Pouch

GlobeNewswire October 11, 2018

Aptar Announces Change to Date for Third Quarter Conference Call

Business Wire September 26, 2018

Aptar Completes Acquisition of CSP Technologies

Business Wire August 27, 2018